The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studies

Journal of Hepatology

Volumn 56, Issue 2, 2012, Pages 448-454

  Al Serri, Ahmad ^a   Anstee, Quentin M ^a   Valenti, Luca ^c   Nobili, Valerio ^b   Leathart, Julian B S ^a   Dongiovanni, Paola ^c   Patch, Julia ^a   Fracanzani, Anna ^c   Fargion, Silvia ^c   Day, Christopher P ^a   Daly, Ann K ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Gene; NAFLD; NASH; Oxidative stress; Polymorphism; Steatohepatitis

Indexed keywords

MANGANESE SUPEROXIDE DISMUTASE;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL;

ADULT; BASE SEQUENCE; CASE-CONTROL STUDIES; COHORT STUDIES; DNA PRIMERS; FAMILY; FATTY LIVER; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; LIPASE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SUPEROXIDE DISMUTASE;

EID: 84855978332     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.05.029     Document Type: Article

References (60)

1. L. Cortez-Pinto, M.C. De Moura, and C.P. Day Non-alcoholic steatohepatitis: from cell biology to clinical practice J Hepatol 44 2006 197 208 (Pubitemid 41772535)
2. B.A. Neuschwander-Tetri, and S.H. Caldwell Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference Hepatology 37 2003 1202 1219 (Pubitemid 36538699)
3. I.R. Wanless, and J.S. Lentz Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors Hepatology 12 1990 1106 1110
4. J. Dixon, P. Bhathal, and P. O'Brian Non-alcoholic fatty liver disease: predictors of non-alcoholic steatohepatitis and liver fibrosis in the severely obese Gastroenterology 121 2001 91 100 (Pubitemid 32591518)
5. Q.M. Anstee, A. Daly, and C.P. Day Genetics of alcoholic and non-alcoholic fatty liver disease Semin Liver Dis 31 2011 128 146
6. C.P. Day Pathogenesis of steatohepatitis Best Pract Res Clin Gastroenterol 16 2002 663 678
7. Q.M. Anstee, and R.D. Goldin Mouse models in non-alcoholic fatty liver disease and steatohepatitis research Int J Exp Pathol 87 2006 1 16
8. H. Malhi, G.J. Gores, and J.J. Lemasters Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 43 2006 S31 S44
9. Q.M. Anstee, D. Concas, H. Kudo, A. Levene, J. Pollard, and P. Charlton Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis J Hepatol 53 2010 542 550
10. G.C. Farrell, C.Z. Larter, J.Y. Hou, R.H. Zhang, M.M. Yeh, and J. Williams Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression J Gastroenterol Hepatol 24 2009 443 452
11. C.P. Day From fat to inflammation Gastroenterology 130 2006 207 210 (Pubitemid 43049850)
12. J.P. Iredale Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ J Clin Invest 117 2007 539 548 (Pubitemid 46348508)
13. V.M. Struben, E.E. Hespenheide, and S.H. Caldwell Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds Am J Med 108 2000 9 13 (Pubitemid 30058272)
14. I.R. Willner, B. Waters, S.R. Patil, A. Reuben, J. Morelli, and C.A. Riely Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease Am J Gastroenterol 96 2001 2957 2961 (Pubitemid 32959539)
15. L.A. MacMillan-Crow, and D.L. Cruthirds Invited review - manganese superoxide dismutase in disease Free Radic Res 34 2001 325 336 (Pubitemid 32331659)
16. S. Shimoda-Matsubayashi, H. Matsumine, T. Kobayashi, Y. Nakagawa-Hattori, Y. Shimizu, and Y. Mizuno Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease Biochem Biophys Res Commun 226 1996 561 565 (Pubitemid 26331940)
17. A. Sutton, A. Imbert, A. Igoudjil, V. Descatoire, S. Cazanave, and D. Pessayre The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability Pharmacogenet Genomics 15 2005 311 319 (Pubitemid 40676552)
18. A. Sutton, H. Khoury, C. Prip-Buus, C. Cepanec, D. Pessayre, and F. Degoul The Ala(16)Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria Pharmacogenetics 13 2003 145 157 (Pubitemid 36324244)
19. L. Valenti, D. Conte, A. Piperno, P. Dongiovanni, A.L. Fracanzani, and M. Fraquelli The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis J Med Genet 41 2004 946 950 (Pubitemid 40007257)
20. M.I. Lucena, E. Garcia-Martin, R.J. Andrade, C. Martinez, C. Stephens, and J.D. Ruiz Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injury Hepatology 52 2010 303 312
21. C. Namikawa, Z. Shu-Ping, J.R. Vyselaar, Y. Nozaki, Y. Nemoto, and M. Ono Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis J Hepatol 40 2004 781 786 (Pubitemid 38507358)
22. A. Mollsten, S.L. Marklund, M. Wessman, M. Svensson, C. Forsblom, and M. Parkkonen A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy Diabetes 56 2007 265 269
23. A. Mollsten, A. Jorsal, M. Lajer, N. Vionnet, and L. Tarnow The V16A polymorphism in SOD2 is associated with increased risk of diabetic nephropathy and cardiovascular disease in type 1 diabetes Diabetologia 52 2009 2590 2593
24. P. Wheatley-Price, K. Asomaning, A. Reid, R. Zhai, L. Su, and W. Zhou Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma Cancer 112 2008 1037 1042 (Pubitemid 351304587)
25. P. Nahon, A. Sutton, D. Pessayre, P. Rufat, F. Degoul, and N. Ganne-Carrie Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death Clin Gastroenterol Hepatol 3 2005 292 298 (Pubitemid 40568736)
26. S.F. Stewart, J.B. Leathart, Y. Chen, A.K. Daly, R. Rolla, and D. Vay Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosis Hepatology 36 2002 1355 1360 (Pubitemid 35403525)
27. R.S. Spielman, and W.J. Ewens The TDT and other family-based tests for linkage disequilibrium and association Am J Hum Genet 59 1996 983 989 (Pubitemid 26346336)
28. V. Nobili, M. Marcellini, R. Devito, P. Ciampalini, F. Piemonte, and D. Comparcola NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice Hepatology 44 2006 458 465 (Pubitemid 44214885)
29. L. Valenti, A.L. Fracanzani, P. Dongiovanni, G. Santorelli, A. Branchi, and E. Taioli Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease Gastroenterology 122 2002 274 280 (Pubitemid 34116980)
30. E.M. Brunt, C.G. Janney, A.M. Di Bisceglie, B.A. Neuschwander-Tetri, and B.R. Bacon Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am J Gastroenterol 94 1999 2467 2474 (Pubitemid 29420675)
31. A.K. Daly, K.S. Fairbrother, O.A. Andreassen, S.J. London, J.R. Idle, and V.M. Steen Characterization and PCR-based detection of two different hybrid CYP2D7P/CYP2D6 alleles associated with the poor metabolizer phenotype Pharmacogenetics 6 1996 319 328 (Pubitemid 26288622)
32. R-Development-Core-Team R: a language and environment for statistical computing 2010 R Foundation for Statistical Computing Vienna, Austria
33. S. Romeo, J. Kozlitina, C. Xing, A. Pertsemlidis, D. Cox, and L.A. Pennacchio Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat Genet 40 2008 1461 1465
34. L. Valenti, A. Al-Serri, A.K. Daly, E. Galmozzi, R. Rametta, and P. Dongiovanni Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease Hepatology 51 2010 1209 1217
35. Y.B. Li, T.T. Huang, E.J. Carlson, S. Melov, P.C. Ursell, and T.L. Olson Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide-dismutase Nat Genet 11 1995 376 381
36. J.E. Kokoszka, P. Coskun, L.A. Esposito, and D.C. Wallace Increased mitochondrial oxidative stress in the Sod2 (+/-) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis Proc Natl Acad Sci USA 98 2001 2278 2283 (Pubitemid 32209473)
37. M. Pan, A.I. Cederbaum, Y.L. Zhang, H.N. Ginsberg, K.J. Williams, and E.A. Fisher Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production J Clin Invest 113 2004 1277 1287 (Pubitemid 39069927)
38. J. Lenart, F. Dombrowski, A. Gorlach, and T. Kietzmann Deficiency of manganese superoxide dismutase in hepatocytes disrupts zonated gene expression in mouse liver Arch Biochem Biophys 462 2007 238 244 (Pubitemid 46856321)
39. C.H. Osterreicher, J. Schultheiss, M. Wehler, N. Homann, C. Hellerbrand, and B. Kunzli Genetic polymorphisms of manganese-superoxide dismutase and glutathione-S-transferase in chronic alcoholic pancreatitis Mutagenesis 22 2007 305 310 (Pubitemid 47357601)
40. M.G. Petrovic, I. Cilensek, and D. Petrovic Manganese superoxide dismutase gene polymorphism (V16A) is associated with diabetic retinopathy in Slovene (Caucasians) type 2 diabetes patients Dis Markers 24 2008 59 64 (Pubitemid 350174571)
41. J. Tomkins, S.J. Banner, C.J. McDermott, and P.J. Shaw Mutation screening of manganese superoxide dismutase in amyotrophic lateral sclerosis NeuroReport 12 2001 2319 2322 (Pubitemid 32682180)
42. J.K. Reddy, and M.S. Rao Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation Am J Physiol Gastrointest Liver Physiol 290 2006 G852 858
43. M.S. Rao, and J.K. Reddy Peroxisomal beta-oxidation and steatohepatitis Semin Liver Dis 21 2001 43 55
44. D. Pessayre, and B. Fromenty NASH: a mitochondrial disease J Hepatol 42 2005 928 940 (Pubitemid 40693212)
45. D. Pessayre Role of mitochondria in non-alcoholic fatty liver disease J Gastroenterol Hepatol 22 2007 S20 27
46. G. Serviddio, F. Bellanti, R. Tamborra, T. Rollo, N. Capitanio, and A.D. Romano Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury Gut 57 2008 957 965 (Pubitemid 351919530)
47. A. Martinelli, S. Knapp, Q. Anstee, M. Worku, A. Tommasi, and S. Zucoloto Effect of a thrombin receptor (protease-activated receptor 1, PAR-1) gene polymorphism in chronic hepatitis C liver fibrosis J Gastroenterol Hepatol 23 2008 1403 1409
48. M. Wright, R. Goldin, S. Hellier, S. Knapp, A. Frodsham, and B. Hennig Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection Gut 52 2003 1206 1210 (Pubitemid 36877437)
49. L. Miele, G. Beale, G. Patman, V. Nobili, J. Leathart, and A. Grieco The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease Gastroenterology 135 2008 282 291 e281
50. R. Bataller, K.E. North, and D.A. Brenner Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal Hepatology 37 2003 493 503 (Pubitemid 36258768)
51. J.E. Nelson, R. Bhattacharya, K.D. Lindor, N. Chalasani, S. Raaka, and E.J. Heathcote HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis Hepatology 46 2007 723 729 (Pubitemid 47436118)
52. Q.M. Anstee, R.D. Goldin, M. Wright, A. Martinelli, R. Cox, and M.R. Thursz Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies J Thromb Haemost 6 2008 1336 1343 (Pubitemid 352016314)
53. M. Yoneda, K. Hotta, Y. Nozaki, H. Endo, T. Uchiyama, and H. Mawatari Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease Liver Int 29 2009 1078 1085
54. S. Merat, R. Malekzadeh, M.R. Sohrabi, M. Sotoudeh, N. Rakhshani, and A.A. Sohrabpour Probucol in the treatment of non-alcoholic steatohepatitis: a double-blind randomized controlled study J Hepatol 38 2003 414 418 (Pubitemid 36399242)
55. M.F. Abdelmalek, P. Angulo, R.A. Jorgensen, P.B. Sylvestre, and K.D. Lindor Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study Am J Gastroenterol 96 2001 2711 2717
56. J.E. Lavine Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study J Pediatr 136 2000 734 738 (Pubitemid 30415645)
57. F.S. Facchini, N.W. Hua, and R.A. Stoohs Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease Gastroenterology 122 2002 931 939 (Pubitemid 34267276)
58. S.A. Harrison, S. Torgerson, P. Hayashi, J. Ward, and S. Schenker Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis Am J Gastroenterol 98 2003 2485 2490 (Pubitemid 37448761)
59. J.F. Dufour, C.M. Oneta, J.J. Gonvers, F. Bihl, A. Cerny, and J.M. Cereda Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis Clin Gastroenterol Hepatol 4 2006 1537 1543 (Pubitemid 44880031)
60. A.J. Sanyal, N. Chalasani, K.V. Kowdley, A. McCullough, A.M. Diehl, and N.M. Bass Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis N Engl J Med 362 2010 1675 1685